Raghvendra Bohara
CrannMed Ltd, National University of Ireland Galway, D.Y.Patil University, Kolhapur
About
Dr Raghvendra A. Bohara is a Senior Scientist at CrannMed, leveraging his extensive experience in cancer nanomedicine to advance innovative embolization technology. Previously, Dr. Bohara conducted groundbreaking research at the University of Galway, where he developed targeted drug delivery systems using biomaterials-based formulations. His work has resulted in over 80 publications in esteemed journals and has been recognized with prestigious awards, including the Government of Ireland Postdoctoral Fellowship, amongst others. Dr. Bohara's dedication to improving patient outcomes and his expertise in designing cutting-edge solutions make him a valuable asset to CrannMed's mission of alleviating chronic pain
Employment
-
CrannMed Ltd Senior Scientist2024 - Present
-
National University of Ireland Galway Irish council Postdoctoral Fellow2018 - Present
Education
-
D.Y.Patil University, Kolhapur PhD
Projects & Funding
Projects & funding information is unavailable.
Publications (37)
- Drug loading within resorbable alginate embolisation microspheres Save
- Drug loading within resorbable alginate embolisation microspheres Save
- Silver Nanoparticle-Reinforced Silk Fibroin-Polyvinyl alcohol Composite Films Potential Wound Dressing Material: Antimicrobial Activity, Swelling Behavior, and Hemostatic Performance Save
- Selective Anticancer Activity and Safety Profile of Chlorochalcones: Impact on Breast Cancer, Blood, and Endothelial Cells Save
- Advanced Strategies in Enhancing the Hepatoprotective Efficacy of Natural Products: Integrating Nanotechnology, Genomics, and Mechanistic Insights Save
- Novel delivery strategy: finasteride-loaded solid lipid nanoparticles for improved androgenetic alopecia therapy Save
- Hybrid silver nanoparticles: Modes of synthesis and various biomedical applications Save
- Acne vulgaris: A review of the pathophysiology, treatment, and recent nanotechnology based advances Save
- Nitric Oxide-Scavenging, Anti-Migration Effects, and Glycosylation Changes after Hemin Treatment of Human Triple-Negative Breast Cancer Cells: A Mechanistic Study Save
- Glucose‐Responsive Fibrin Hydrogel‐Based Multimodal Nucleic Acid Delivery System Save